Hillhouse Investment is a global private equity firm with an East Asian heritage. Hillhouse was founded by Lei Zhang in 2005 with initial seed capital from the Yale University endowment and invests across East Asia, Southeast Asia, North America, and Europe. Hillhouse has Asian offices in Singapore,  Hong Kong, Beijing and Shanghai with additional international offices in New York City and London.
 Hillhouse's assets under management ("AUM") were US$73.3 billion as of July 2021. In October 2021, Hillhouse raised US$18 billion for its fifth flagship private equity fund, breaking the previous record set by KKR's US$15 billion pan-Asia private equity fund raised that same year.
 Hillhouse manages capital for institutional clients such as university endowments, foundations, sovereign wealth funds, pension funds, and family offices. Hillhouse is a long-term fundamental research-driven equity investor, investing in all equity stages in sectors including consumer, healthcare, technology, and financials services.
 Lei Zhang founded Hillhouse Investment in June 2005 with an initial US$20 million of seed capital from the Yale University endowment through David Swensen, Yale's Chief Investment Officer at the time. 
 By 2017, the firm had participated in more private equity acquisitions in the Asia-Pacific region than any other private equity firm, totaling $26 billion worth of transactions.
 In 2020, Hillhouse spun off its venture capital unit into an independent fund. The new fund is called GL Ventures. As of 2020, Hillhouse was an investor in companies such as Airwallex.  Hillhouse Capital was nearing raising US$18 billion to back three new funds in May 2021, higher than the projected $13 billion in April 2021, according to reports, with $10 billion to be allocated to buyouts, and the rest "split between growth equity and venture." The company at the time was managing $100 billion. In August 2021, Hillhouse completed fundraising for its fifth flagship private equity investment fund at US$18 billion, the largest amount of capital raised by any private equity firm in Asia and breaking the previous record set by KKR's US$15 billion pan-Asia private equity fund, also raised in 2021.
 In 2022, Hillhouse started its first real estate-focused fund, the Hillhouse Real Asset Opportunities Fund (RAOF), with a total investment of more than $2 billion.
 Hillhouse's rapid growth stemmed from its investing track record, with up to 52% annualized returns from inception until 2012 and continued strong performance as the firm scaled.
 Tencent Holdings Ltd: Some original $20 million provided from Yale was invested in Tencent Holdings in 2005. It was Hillhouse's earliest investment and one of their most profitable.
 JD.com: Hillhouse was an early investor in JD.com. At the time of the listing of JD.com on NASDAQ in May 2014, the company was valued at $26 billion. Hillhouse's original $255 million investment was, at the time of the IPO, valued at $3.9 billion.
 Blue Moon: Hillhouse invested in Blue Moon, a liquid detergent maker, in 2010 as its only outside institutional investor.
 Belle International: In July 2017, Hillhouse purchased footwear company Belle International for $6.8 billion.
 Global Logistic Properties: Hillhouse, together with Hopu Investment Management, purchased Singapore-based warehouse operator Global Logistic Properties in 2017 for $12 billion. At the time, it was the largest buyout of an Asian company.
 Little Freddie: In 2018, Hillhouse began investing in the food sector, including organic baby food and snack manufacturer Little Freddie, a Californian craft beer maker and a pet food brand.
 Miniso: In October 2018, Hillhouse signed a strategic investment agreement with Japanese-style retailer Miniso worth RMB 1 billion ($145.6 million).
 Philips Domestic Appliances: In August 2021, Hillhouse closed the deal of acquisition on the global 
domestic appliances business from Dutch conglomerate Philips.
 LifeStyles Healthcare: In December 2020, Hillhouse invested in Lifestyles Healthcare, an Australian global 
manufacturer of sexual wellness products. The company entered the Chinese market in 2006 after 
acquiring Jissbon.
 Gimborn: In 2016 Hillhouse acquired Gimborn, a German producer of cat litter and pet supplements, for an undisclosed sum.
 Zoom: Hillhouse was an investor in Zoom Video Communications in an early funding round in February 2015.
 Pete's Coffee: In 2017, Peet’s announced the formation of Peet’s Coffee China, an independently run joint venture formed by Peet’s Coffee and Hillhouse Capital.
 BeiGene: Hillhouse co-led a round of financing for biotechnology company BeiGene in May 2015.
 Hillhouse established an exclusive joint venture focused on China with the US healthcare provider, Mayo Clinic. Hillhouse works with the Mayo organization to expand its healthcare outreach in China.
 In November 2017, Peet's Coffee China, a partnership between Hillhouse Capital and San Francisco-based Peet's Coffee, opened the first Peet's Coffee roastery in Shanghai.
 Hillhouse does deep and fundamental research on industries and business models, and applies the value investing philosophy in local contexts while investing in different geographies.
 According to the Financial Times, Hillhouse will often bring together leaders of their portfolio companies to share insights, believing that it is beneficial for executives to learn from one another.
 When it comes to buyout investments in traditional industries, Hillhouse has argued that technological innovation can be harnessed for job creation, saying that technology can act as an "equalizer" as opposed to a "disruptor."
 According to the Wall Street Journal, Stanford University pledged to invest about US$200 million with Hillhouse in August 2015. With Stanford's investment, the firm manages "money for at least six of the 10 wealthiest universities in the U.S."
 The other university investors in Hillhouse include Princeton University, Massachusetts Institute of Technology, University of Pennsylvania, University of Texas, and Yale University.
 CPPIB committed US$200 million to Fund II in 2014, US$300 million to Fund III in 2016, and US$300 million to Fund IV in 2018.